Key result
Frailty in diabetic patients is linked to ~2% higher HbA1c and elevated inflammatory indices.
Why the study?
Frailty increases hospitalization risk in diabetic patients, and both the SARS-CoV-2 pandemic and type 2 diabetes contribute to frailty.
Cross-Sectional (n=100)
No
HbA1c, MPV, and MLR are significantly correlated with frailty scores in elderly diabetic patients during the COVID-19 pandemic, suggesting their potential use as surrogate markers.
Answers are grounded in this paper and cite their sources.
May warrant frailty screening in diabetes; leaves open whether frailty drives or results from hyperglycemia and inflammation.
Background: Frailty is associated with increased risk of hospitalization in diabetic patients. Both SARS-CoV-2 pandemic and type 2 diabetes mellitus contribute to the frailty. In this study we aimed to observe clinical and laboratory indices of the diabetic subjects during COVID-19 pandemic who were either frail or not according to Edmonton frail score. Material and methods: During the pandemic era, 100 consecutive patients with type 2 diabetes mellitus divided into two groups either as frail or non-frail according to the Edmonton Frail Scale scores. Laboratory and clinical features of the frail and non-frail subjects were compared. Results: Frail patients were older than the non-frail diabetics. Blood urea, serum creatinine, eGFR, plasma albumin, total cholesterol, triglyceride, HbA1c, mean platelet volume (MPV), and monocyte lymphocyte ratio (MLR) levels of the frail and non-frail groups were significantly different. Moreover, Edmonton frail score was significantly and positively correlated with blood urea, serum creatinine, MLR, MPV, HbA1c and inversely correlated with eGFR and plasma albumin levels. Conclusions: We think that HbA1c, MPV and MLR could be surrogate markers of frailty in diabetic elderly during COVID-19 outbreak. Strategies to keep them in normal range do not only improve diabetes control but also reduce the risk of frailty in this population.
No takes yet. Share an insight, caveat, or question.
Tel et al. (2022) conducted a cross-sectional in Type 2 diabetes mellitus (n=100). Frailty (Edmonton Frail Scale score ≥ 8) vs. Non-frail (Edmonton Frail Scale score ≤ 7) was evaluated on Mean HbA1c level (p=<0.001). Frail diabetic patients had higher HbA1c, mean platelet volume, and monocyte/lymphocyte ratio compared to non-frail patients.
Synapse has enriched 10 related papers. Consider them for comparative context: